We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$188M
AUM Growth
+$5.63M
Cap. Flow
-$65.4M
Cap. Flow %
-34.76%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$3.52M
2
PHIO icon
Phio Pharmaceuticals
PHIO
+$2.13M
3
ACHV icon
Achieve Life Sciences
ACHV
+$589K

Top Sells

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$34.5M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$6.32M

Sector Composition

Rank Sector Weight
1 Healthcare 78.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$71.6M 38.07%
4,919,625
– –
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$39.2M 20.87%
2,144,387
– –
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.5B
$22.7M 12.08%
182,300
– –
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11.4M 6.06%
388,543
+150,111
+63% +$3.52M
ACHV icon
5
Achieve Life Sciences
ACHV
$626M
$1.35M 0.72%
286
+120
+72% +$589K
PHIO icon
6
Phio Pharmaceuticals
PHIO
$12.1M
$1.13M 0.6%
+3
New +$2.13M
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-490,000
Closed -$6.32M
SLXP
8
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-300,000
Closed -$34.5M

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Tang Capital Management held 10 positions worth $188M, up 3.1% from $182M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management withdrew a net $65.4M in Q1 2015, closing 2 positions. Its most notable exit was SALIX PHARMACEUTICALS LTD DEL, an estimated $34.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 64% a quarter earlier.

Against the trend, Tang Capital Management opened a new position in Phio Pharmaceuticals worth $1.13M.

  • Tang Capital Management's largest Q1 2015 buy was Phio Pharmaceuticals: 3 shares worth $1.13M.
  • Tang Capital Management added most to Mirati Therapeutics, Inc. Common Stock in Q1 2015, an estimated $3.52M increase.
  • Tang Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q1 2015, selling an estimated $34.5M.
  • Tang Capital Management's ten largest holdings make up 100% of its $188M portfolio in Q1 2015.
  • Tang Capital Management opened 1 new position and closed 2 in Q1 2015.
  • Tang Capital Management's portfolio value rose 3.1% quarter-over-quarter to $188M.

Based on Tang Capital Management's 13F filing for Q1 2015, filed 15 May 2015.